Recent discoveries suggesting essential bioactivities of nitric oxide (NO') in the lung are difficult to reconcile with the established pulmbnary cytotoxicity of this common air pollutant. These conflicting observations suggest that metabolic intermediaries may exist in the lung to modulate the bioactivity and toxicity of NO'. We report that S-nitrosothiols (RS-NO), predominantly the adduct with glutathione, are present at nano-to micromolar concentrations in the airways of normal subjects and that their levels vary in different human pathophysiologic states. These endogenous RS-NO are longlived, potent relaxants of human airways under physiological 02 concentrations. Moreover, RS-NO form in high concentrations upon administration of NO gas. Nitrite (10-20 ,M) is found in airway lining fluid in concentrations linearly proportional to leukocyte counts, suggestive of local NO' metabolism. NO itself was not detected either free in solution or in complexes with transition metals. These observations may provide insight into the means by which NO is packaged in biological systems to preserve its bioactivity and limit its potential 02-dependent toicity and suggest an important role for NO' in regulation of airway luminal homeostasis.
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There is accumulating evidence that nitric oxide (NO') is produced in mammalian airways: constitutive and inducible forms of NO synthase have recently been identified in the lung (1, 2) , oxides of nitrogen (NOx) are produced by airway cells (3) , and exhaled NO gas can be measured in nonsmoking volunteers (4) . Potential sources of NO' include the lung parenchyma itself [smooth muscle, mast cells, nerves, and epithelium (1-3, [5] [6] [7] [8] ] as well as the cellular constituents of airway lining fluid [macrophages and neutrophils (1, 2, [9] [10] [11] ]. NO has well established vasodilator properties that may play a role in the physiological regulation of blood flow and pressure in the pulmonary circulation (12) . Although more disputed (13) , the smooth muscle relaxant effects of NO' in airways suggest that it may have an additional role as a bronchodilator (14) (15) (16) .
NO', a common air pollutant and component of cigarette smoke, has been viewed as highly toxic to the lung, in part as a consequence of the high ambient 02 tension (17) (18) (19) (20) (21) (22) . The reactions of NO with ambient 02 and superoxide (02 ) yield more reactive NO,, including nitrogen dioxide (NO) and peroxynitrite (OONO-), which are implicated in bronchiolitis and lung edema (17, 20, 21, 23, 24) . There is additional concern that the oxidative metabolism of NO may lead to formation of carcinogenic nitrosoamines (25, 26) . Notably, these oxidative reactions of NO also result in the rapid loss of its smooth muscle relaxant activity (27, 28) .
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An alternative metabolic pathway for NOI of potential biological relevance involves the reaction with thiols yielding S-nitrosothiols (RS-NO) (28) . According to recent observations, RS-NO possessing biological activity are abundant in plasma compared to reactive free NO' (29) . Moreover, these RS-NO adducts appear to be more stable than NO' itself (30, 31) . Given that endogenous thiol is prevalent in the lung in the form of glutathione (32) , we hypothesized that RS-NO may serve the dual function in airways of stabilizing NO in bioactive form and modifying its cytotoxic potential. We also sought to identify other endogenous NO, and iron-nitrosyl adducts present in human airways.
METHODS
Subjects. Airway fluid samples were obtained from 20 normal subjects, 16 subjects with pulmonary disease, and 2 subjects receiving inhaled NO gas for treatment for pulmonary hypertension. Normal subjects (13 ± 2.5 years old) were defined as nonsmokers with normal pulmonary examinations and no history of respiratory illness. Bronchoalveolar lavage fluid (BALF) (i.e., fluid from the distal airways and alveoli) was obtained from 6 healthy volunteers (25 ± Proc. Natl. Acad. Sci. USA 90 (1993) established methods: (i) NO, liberated by photolytic cleavage of RS-NO, was measured by chemiluminescence as recently described (29); (ii) verification of RS-NO concentration was made by the method of Saville (33) , in which the NO group is measured colorimetrically after its displacement by HgCl2. RS-NO levels were closely correlated by using the two assay methodologies (r = 0.85; P = 0.00042) within the limits of sensitivity of the Saville assay (n = 11; >150 nM), confirming previous reports (29, 31) . In additional cases in which analysis of BALF by Saville was limited by its excessive dilution (see below), the presence of RS-NO was confirmed by the addition of Saville reagents (in the presence and absence of HgCl2) directly to the lavage samples, which were then subjected to concentration under vacuum (Speed-Vac; Savant). Controls were prepared in the presence of excess free thiol (glutathione and/or cysteine) and nitrite (NO-) at concentrations exceeding those in the lavage to exclude artifactual formation of RS-NO. RS-NO were synthesized as standards [and for bioassays (see below)], using equivalent concentrations of thiol (in H20) and acidified NaNO2 (1 M HCl). Details of this method have been published (34) . NO2
was assayed by the Griess reaction, involving diazotization of sulfanilamide and subsequent coupling to N-(1-naphthyl)ethylenediamine (29, 31) . NO was assayed by chemiluminescence measurements made without chemical reduction of samples or photolysis (29) . Transition metal-NO complex formation was measured by EPR on the TA and BALF cell pellet and supernatant at 0°C (flat cell) and 77 K (fused silica EPR tube) in a Varian E-109 spectrometer. Exemplary irondinitrosyl complexes (with cysteine, glutathione, and albumin) were synthesized by established methods (35, 36) and used as standards. Additional spectroscopic references for NO-heme protein complex formation in BALF extracts were obtained from Maples and coworkers (37) . In selected studies, the possible contribution of iron-nitrosyl species to other NO determinations (see above) was excluded by the addition of 500 ,uM EDTA to lavage samples. Sulfhydryls were assayed with Ellman's reagent, 5,5'-dithiobis(2-nitrobenzoic acid) (38) . BALF values were corrected for the dilution effect of lavage by comparison of serum and BALF urea nitrogen levels (urease endpoint) (39 (40) .
Oxygen-Dependent Synthesis and Decomposition of RS-NO.
To study possible mechanisms of RS-NO formation in airway lining fluid, purified NO gas was bubbled into physiological solutions (10 mM PO-, pH 7.4) containing glutathione. Oxygen tension was regulated with a Bird blender and NO and NOi concentrations were determined by on-line chemiluminescence (Thermoenvironmental Institute, Franklin, MA).
The toxicity of free NO has been related to its oxygendependent decomposition (17) . The stability of endogenous RS-NO was therefore studied in bronchoalveolar lavage at different oxygen tensions. Time-dependent degradation of specific RS-NO was assessed by UV spectroscopy using their absorption maximum of =340 nm (30, 31) , accompanied by the measured accumulation of the end degradation product, NO- (Fig. 1) . RS-NO were 10-fold lower in the TA of ECMO patients (0.056 ± 0.027 .uM) than in normal TA (P < 0.05) (Fig. 2) (Fig. 2) .
Relationship of NO. and RS-NO Concentrations to the Chemical and Cellular Constituents of Airway Aspirate Fluid (Table 1) . BALF NO-concentrations increased linearly with macrophage counts (P < 0.05) and total leukocyte counts (P (n = 9) and pneumonia patients (n = 3) are greater than in normal subjects (n = 6) (*, P < 0.05). Tracheal lining fluid RS-NO concentrations in patients on ECMO (n = 4) are less than in normal subjects (n = 19) (*, P < 0.05). Levels of RS-NO increase significantly in upper airway aspirates upon administration of inhaled NO gas (n = 2) (P < 0.05). < 0.005). A similar trend was also observed with neutrophils (P = 0.09), but not with epithelial cell or erythrocyte counts (P = not significant). RS-NO concentrations were directly proportional to free thiol levels (P < 0.05) but did not correlate significantly with NO-levels or airway cell counts (P = not significant). BALF pH ranged from 6.12 to 6.83 (mean, 6.25 ± 0.12) in normal subjects and from 6.0 to 7.6 in patients with lung pathology. RS-NO levels increased with increasing pH (6.0-7.6) (P < 0.01), and concentrations in BALF with pH < 6.9 were lower than those in more alkaline fluid (P < 0.005). N02 concentrations were independent of pH. Supporting these findings, RS-NO formed relatively rapidly on bubbling NO gas (40-80 ppm) into physiologic solutions supplemented with 500 ,uM glutathione. Moreover, the levels of RS-NO and the stoichiometric ratio of RS-NO/ NO, over time were dependent on a variety of factors including NO concentration, 02 tension, thiol concentrations, pH, and the presence or absence of contaminant redox metals.
RS-NO Characterization. In normal subjects, RS-NO in BALF was found to be resistant to rapid precipitation by trichloroacetic acid (7%; 4°C), which precipitates protein RS-NO (29) but not amino acid or small peptide derivatives. Limited artifactual formation of RS-NO, incurred by the acidic conditions, was prevented by the addition of N-ethylmaleimide (>100-fold excess over thiol for 20 min at 4°C) to alkylate free thiols and/or ammonium sulfamate, which removes excess nitrite (33) . These findings were further (32) and strongly suggest that the thiyl moiety (RS) in RS-NO is glutathione. In further support of this identity, the half-life of endogenous RS-NO in the lavage fluid is =3 hr and is essentially identical to that of exogenous GS-NO (Fig. 3) ; notably, the half-life of S-nitrosocysteine is <3 min under these conditions (data not shown). The kinetics of decomposition of GS-NO in BALF are influenced by both 02 tension and pH. In 95% 02 the half-life of GS-NO is =60 min (Fig. 3) . In keeping with the relationship between BALF pH and endogenous RS-NO concentrations (Table 1) , the stability of GS-NO was determined to increase in proportion to pH over the range 6.0-7.4. The inherent stability ofGS-NO contrasts strikingly with that offree NO', which has a half-life on the order of seconds under similar conditions (41) . In the BALF of patients with disease, RS-NO were identified in protein form to varying degrees (range, 0-50o; mean, 21%). This finding is in accord with the change in protein constituency of airway lining fluid in different pathological conditions and the altered integrity of the alveolar capillary membrane; the predominant BALF protein under similar circumstances has been shown in one study to be albumin (42) , and mucins (mucus proteins) are also unusually rich in cysteine residues.
Human Airway Bioassay. GS-NO induced dose-dependent relaxations of rings contracted with methacholine (IC50 = 12 + 6.1 ,uM) (Fig. 4) . At physiological GS-NO concentrations (250-500 nM), tissues were 30% relaxed. By comparison with classical bronchodilators, GS-NO was 20 times more potent than theophylline (IC50 = 243 ± 21 ,M) and 150 times less potent than isoproterenol (IC50 = 0.083 ± 0.063 ,uM). At physiological concentrations of NO (15 ,uM) , airways were 10% relaxed (IC50 = 278 + 57 uM). The exemplary protein RS-NO, S-nitrosoalbumin, did not differ significantly from GS-NO in potency of airway relaxation (Table 2) . GS-NO > NO2 = glutathione (*, P < 0.05; t, P < 0.0005).
DISCUSSION
Our findings provide indirect evidence for local NOx metabolism in human airways and further establish that: (i) RS-NO are present in the airways of normal subjects; (ii) these NO adducts are relatively resistant to inactivation at physiological 02 concentrations as compared to NO itself; (iii) RS-NO possess potent bronchodilator activity and are present in concentrations potentially sufficient to influence airway tone; and (iv) levels of RS-NO vary significantly in different pathological conditions and increase upon administration of NO gas. Taken together, these observations suggest that RS-NO may play a role in modulation of airway lumenal homeostasis.
The contributions of NO to both physiological and pathological processes in the lung are poorly understood. The accumulating evidence for essential biological actions of NO needs to be reconciled with an extensive literature implicating NOx in lung inflammation, impairment of lung function, and induction of lung tumors (17) . Accordingly, the observations of RS-NO (GS-NO) formation from both endogenous and exogenous sources of NO may have important implications. It has been previously shown that the NOx content of smoke correlates with its cytotoxicity (18) , whereas glutathione protects against smoke-induced injury (43) . Furthermore, uptake ofexogenous NO, in rat BALF is a glutathione- dependent process (44) , and glutathione inhibits leukocytemediated N-nitrosation reactions (45)-the latter of some concern for their carcinogenic potential (17, 25, 26) . Glutathione has also been reported to scavenge OONO-, leading to formation of GS-NO (53) . Thus, the formation of GS-NO may provide a means of limiting the toxicity of NO, attributable to its rapid oxidative metabolism, while simultaneously stabilizing NO in bioactive form. Other findings of this study and previous observations (46, 47) suggest that the pH, thiol concentration, and general redox state of the airway will affect the rate of formation, identity, and stability of RS-NO. Hence, physiochemical parameters in the lung may influence the susceptibility to NO'-dependent injury and the formation of endogenous carcinogens. Airway NO2 levels appear to represent an indicator ofNO production by macrophages. Rodent macrophages demonstrate high output, cytokine-induced NOx generation that is important in host defense (48) . However, controversy exists concerning the relevance ofthis observation to human pathophysiology. The detection of NO-in the airways of all subjects in concentrations proportional to macrophage cell counts corroborates limited evidence that the human macrophage is a likely source of NO synthesis (49) . Lending further support to this possibility, we recently found that human alveolar macrophages immunostain for inducible NO synthase in areas of chronic inflammation (2) . The cytostatic activity of activated macrophages in vitro is associated with nitrosylation of iron-sulfur centers (27, 48) . We were, however, unable to detect iron-nitrosyls in the airways of normal subjects or in inflammatory disease settings, indicating levels at least 1-2 orders of magnitude lower than RS-NO, and confirming a previous report (37) .
RS-NO concentrations in airway secretions are predictably dependent on thiol levels, but their independence of airway lining fluid NO-levels and cell counts suggests that their formation may be regulated for a specific biological purpose. In this regard, RS-NO have-in addition to the bronchodilator activity demonstrated in this study-been implicated in vasorelaxation (12) , bacteriostasis (50) , inhibition of ligandgated receptor activity (51) , and modulation of enzyme activity (28) . Although the site and mechanism of RS-NO formation in the lungs are not known, the finding of increased airway RS-NO in inflamed (pneumonia) and transplanted lungs suggests that inflammation and/or immune activation may be important effectors of RS-NO generation. These conclusions, however, may be limited by the complex cellular effects of glucocorticoids, antimicrobials, and other immunosuppressant therapy in these patients. Furthermore, infants on ECMO have low airway RS-NO levels. Whether this reflects the pathophysiology of the newborn gas exchange unit or the effect ofpartially diverting blood flow from the pulmonary artery, it suggests that the pulmonary vasculature may influence airway RS-NO concentrations as well. That RS-NO form upon inhalation of NO gas indicates that RS-NO can form in the extracellular airway environment, probably indirectly through reaction with 02 (52), and provides a second mechanism (i.e., in addition to inactivation by alveolar capillary hemoglobin) for the relative pulmonary vasodilator selectivity of this therapeutic modality.
In summary, we have provided supporting evidence for local NOx metabolism in human airways and identified a class of bronchodilator in the form of RS-NO. These observations may provide insight into the means by which NO is packaged in biological systems to preserve its bioactivity and limit its potential 02-dependent toxicity. As such, our findings may have implications for nontoxic therapeutic delivery of NO in clinical settings. The discovery of an endogenous bronchodilator reservoir in human airways suggests that our current understanding of the regulation of airway luminal homeostasis in general, and airway smooth muscle tone in particular, Proc. Natl. Acad. Sci. USA 90 (1993) 10961 deserves reevaluation. These findings notwithstanding, the biological role of RS-NO in the airway and their relevance to the pathophysiology of human lung disease remains to be shown.
